Finished Dosage Form (FDF) import of Omilancor obtained from Indian Custom Trade Statistics

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Bt-11, 1912399-75-7, A4y49h6yy8, Chembl4788758, Piperazine-1,4-diylbis((6-(1h-benzo[d]imidazol-2-yl)pyridin-2-yl)methanone), [4-[6-(1h-benzimidazol-2-yl)pyridine-2-carbonyl]piperazin-1-yl]-[6-(1h-benzimidazol-2-yl)pyridin-2-yl]methanone
Molecular Formula
C30H24N8O2
Molecular Weight
528.6  g/mol
InChI Key
MVHWZNBAQIGPOQ-UHFFFAOYSA-N
FDA UNII
A4Y49H6YY8

Omilancor
1 2D Structure

Omilancor

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[4-[6-(1H-benzimidazol-2-yl)pyridine-2-carbonyl]piperazin-1-yl]-[6-(1H-benzimidazol-2-yl)pyridin-2-yl]methanone
2.1.2 InChI
InChI=1S/C30H24N8O2/c39-29(25-13-5-11-23(31-25)27-33-19-7-1-2-8-20(19)34-27)37-15-17-38(18-16-37)30(40)26-14-6-12-24(32-26)28-35-21-9-3-4-10-22(21)36-28/h1-14H,15-18H2,(H,33,34)(H,35,36)
2.1.3 InChI Key
MVHWZNBAQIGPOQ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CN(CCN1C(=O)C2=CC=CC(=N2)C3=NC4=CC=CC=C4N3)C(=O)C5=CC=CC(=N5)C6=NC7=CC=CC=C7N6
2.2 Other Identifiers
2.2.1 UNII
A4Y49H6YY8
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Bt-11

2. 1912399-75-7

3. A4y49h6yy8

4. Chembl4788758

5. Piperazine-1,4-diylbis((6-(1h-benzo[d]imidazol-2-yl)pyridin-2-yl)methanone)

6. [4-[6-(1h-benzimidazol-2-yl)pyridine-2-carbonyl]piperazin-1-yl]-[6-(1h-benzimidazol-2-yl)pyridin-2-yl]methanone

7. Omilancor

8. Omilancor [inn]

9. Unii-a4y49h6yy8

10. Bt11

11. Schembl17706588

12. Gtpl10363

13. Bcp32788

14. Bt 11; Bt11

15. Example 1 [us9556146b2]

16. Bdbm50558735

17. S6419

18. Akos037515592

19. Cs-7521

20. Sb18706

21. Hy-102013

22. J3.612.231e

2.4 Create Date
2016-08-06
3 Chemical and Physical Properties
Molecular Weight 528.6 g/mol
Molecular Formula C30H24N8O2
XLogP33.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count4
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area124
Heavy Atom Count40
Formal Charge0
Complexity840
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty